HPV9 Antibody Test (Advance)

Up to 99.7% of cervical cancer is related to HPV virus

  • About 500,000 new cases of cervical cancer each year
  • Global cervical cancer deaths up to 250,000
  • 90% of cervical cancers are related to HPV 16, 18, 31, 33, 45, 52, 58 high-risk viruses
  • Cervical cancer incidence has risen significantly since the age of 25

HPV vaccine effectively prevents cervical cancer and genital warts

HPV vaccine produces antibodies which develop immunity

  • HPV vaccine contains HPV virus capsid protein L1, which is the main antigen and does not cause disease or cancer
  • The vaccine can trigger the body to amalgate virus-like particles (VLP) to produce immune antibodies
  • The antibodies acts as protection and increase the immunity against the HPV virus when one may be exposed to in the future

Designed for people who are vaccinated against HPV

  • The latest HPV antibody test covers all antibodies of the nine-valent HPV vaccine, including HPV6, 11, 16, 18, 31, 33, 45, 52, 58
  • Inoculate HPV vaccine within the time specified by the manufacturer, corresponding HPV antibodies will be detectable after vaccination to ensure adequate protection

Antibody level vary from person to person, double confirmation of vaccine efficiency

  • Different people have different levels of antibodies to HPV vaccine
  • Result being positive indicates the antibody level is strong enough for protection
  • HPV antibody test can test the effectiveness of the vaccine

Test Specifications

Test Code
Methodology
Specimen Requirements
Turnaround Time
IH9
ELISA
3ml clotted-blood
5 working days

Scientific and accurate, measuring the level of antibodies in the blood

  • Capturing HPV6, 11, 16, 18, 31, 33, 45, 52, 58 antibodies in blood using the principle of antibody antigen-specific binding
  • According to the degree of antibody-antigen binding, you can accurately determine the level of 9 antibodies through quantitative experiments

Frequently asked questions (FAQs)

1. When is an HPV antibody test needed?
A: After vaccination: You can test whether the vaccine is effective and to ensure adequate protection.
Vaccinated before: To detect whether the vaccine is still effective to provide protection.
 
2. Is 4-valent vaccinated eligible for HPV 9 antibodies detection?
A: Whether vaccinated with a 4-valent vaccine or a 9-valent vaccine, you can still take HPV9 antibody testing which can detect the antibodies within both vaccinations. 
 
3. Do men need to be vaccinated against HPV and tested for antibodies?
A: HPV vaccine for men can help prevent genital warts and anal cancer. Testing with antibodies will ensure that the vaccine is effective and that there is adequate antibody protection.
 
4. If infected by HPV before, will there be antibodies in my body?
A: For patients who have been infected, certain levels of antibodies are produced in the body.
Studies have shown that patients who have been infected will have a booster response to the vaccine with at least 10 times more antibodies than before the vaccine.

How to get started

Our tests must be ordered by a doctor. Ask your doctor if a Mygenia test is right for you. We can help you find a doctor if you don’t have one.

I have a doctor
References
  1. Preparing for the introduction of HPV vaccines: policy and programme guidance for countries, World Health Organization, Department of Reproductive Health and Research (2006)
  2. http://www.who.int/reproductivehealth/publications/cancers/RHR_06.11/en/
  3. Huh WK, Joura EA, Giuliano AR, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet 2017; 390(10108):2143-2159.